FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sylvie Girardon

Research Profile

Living Beings

Chemicals & Drugs

Concepts & Ideas

Drug Dose Response Relationship

Activities & Behaviors

Co-author Network

Publications

TOP 3
Mauricette Brocco; Anne Dekeyne; Clotilde Mannoury La Cour; Manuelle Touzard; Sylvie Girardon; Sylvie Veiga; Guillaume De Nanteuil; Trynke R deJong; Berend Olivier; Mark J Millan
Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: a comparison to other agents.
Mark J Millan; Per Svenningsson; Charles R Ashby; Michael Hill; Martin Egeland; Anne Dekeyne; Mauricette Brocco; Benjamin Di Cara; Françoise Lejeune; Nitza Thomasson; Carmen Munoz; Elisabeth Mocaër; Alan R Crossman; Laetitia Cistarelli; Sylvie Girardon; Loretta Iob; Sylvie Veiga; Alain Gobert
S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo.
Mark J Millan; Sylvie Veiga; Sylvie Girardon; Mauricette Brocco
Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sylvie Girardon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Mauricette Brocco; Anne Dekeyne; Clotilde Mannoury La Cour; Manuelle Touzard; Sylvie Girardon; Sylvie Veiga; Guillaume De Nanteuil; Trynke R deJong; Berend Olivier; Mark J Millan
Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: a comparison to other agents.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2008;18(10):729-50.
2008: Mark J Millan; Per Svenningsson; Charles R Ashby; Michael Hill; Martin Egeland; Anne Dekeyne; Mauricette Brocco; Benjamin Di Cara; Françoise Lejeune; Nitza Thomasson; Carmen Munoz; Elisabeth Mocaër; Alan R Crossman; Laetitia Cistarelli; Sylvie Girardon; Loretta Iob; Sylvie Veiga; Alain Gobert
S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo.
The Journal of pharmacology and experimental therapeutics 2008;324(2):600-11.
2003: Mark J Millan; Sylvie Veiga; Sylvie Girardon; Mauricette Brocco
Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.
Psychopharmacology 2003;168(4):397-409.
2002: Anne Dekeyne; Alain Gobert; Agnès Auclair; Sylvie Girardon; Mark J Millan
Differential modulation of efficiency in a food-rewarded "differential reinforcement of low-rate" 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitors.
Psychopharmacology 2002;162(2):156-67.
2002: Mark J Millan; Sylvie Girardon; J Mullot; Mauricette Brocco; Anne Dekeyne
Stereospecific blockade of marble-burying behaviour in mice by selective, non-peptidergic neurokinin1 (NK1) receptor antagonists.
Neuropharmacology 2002;42(5):677-84.
2002: Mauricette Brocco; Anne Dekeyne; Sylvie Veiga; Sylvie Girardon; Mark J Millan
Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents.
Pharmacology, biochemistry, and behavior 2002;71(4):667-80.
2000: Mark J Millan; Anne Dekeyne; Adrian Newman-Tancredi; Didier Cussac; Valérie Audinot; G Milligan; Delphine Duqueyroix; Sylvie Girardon; J Mullot; Jean A Boutin; Jean-Paul Nicolas; A Renouard-Try; Jean-Michel Lacoste; Alex Cordi
S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine.
The Journal of pharmacology and experimental therapeutics 2000;295(3):1192-205.
2000: Mark J Millan; Sylvie Girardon; S Monneyron; Anne Dekeyne
Discriminative stimulus properties of the dopamine D3 receptor agonists, PD128,907 and 7-OH-DPAT: a comparative characterization with novel ligands at D3 versus D2 receptors.
Neuropharmacology 2000;39(4):586-98.
1999: Mark J Millan; Sylvie Girardon; Anne Dekeyne
5-HT2C receptors are involved in the discriminative stimulus effects of citalopram in rats.
Psychopharmacology 1999;142(4):432-4.
1999: Anne Dekeyne; Sylvie Girardon; Mark J Millan
Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: a pharmacological analysis.
Neuropharmacology 1999;38(3):415-23.
1999: Mark J Millan; Alain Gobert; Sylvie Girardon; Anne Dekeyne
Citalopram elicits a discriminative stimulus in rats at a dose selectively increasing extracellular levels of serotonin vs. dopamine and noradrenaline.
European journal of pharmacology 1999;364(2-3):147-50.
1997: Mark J Millan; Sylvie Girardon; K Bervoets
8-OH-DPAT-induced spontaneous tail-flicks in the rat are facilitated by the selective serotonin (5-HT)2C agonist, RO 60-0175: blockade of its actions by the novel 5-HT2C receptor antagonist SB 206,553.
Neuropharmacology 1997;36(4-5):743-5.
1996: Mark J Millan; L Seguin; P Honoré; Sylvie Girardon; K Bervoets
Pro- and antinociceptive actions of serotonin (5-HT)1A agonists and antagonists in rodents: relationship to algesiometric paradigm.
Behavioural brain research 1996;73(1-2):69-77.
1995: Mark J Millan; Jean-Louis Peglion; J Vian; Jean-Michel Rivet; Mauricette Brocco; Alain Gobert; Adrian Newman-Tancredi; Catherine Dacquet; K Bervoets; Sylvie Girardon
Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy.
The Journal of pharmacology and experimental therapeutics 1995;275(2):885-98.